Divalproex in pharma franchise in Mizoram

Divalproex in PCD pharma franchise in Gangtok

Divalproex in top pharma company in Surat

Divalproex in pcd pharma supplier in Thane

Divalproex in phama franchise company in India
Divalproex in phama distributor in Visakhapatnam

Home/Products /divalproex-500mg-prolonged-release-tablet

Divalxyle ER 500 Tablet

Composition : Divalproex (500mg) Prolonged Release Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹233/-

Divalproex  ER 500 Tablet is a prolonged-release formulation containing Divalproex Sodium, a medication widely used in the management of neurological and psychiatric conditions. The extended-release mechanism of Divalxyle ensures a steady release of the active ingredient, providing continuous therapeutic effects throughout the day. This formulation reduces the frequency of dosing, improving patient adherence and optimizing treatment outcomes.

Divalproex is a broad-spectrum anticonvulsant that works by stabilizing electrical activity in the brain, making it highly effective in treating epilepsy. It is also used to manage bipolar disorder, specifically for controlling manic episodes, and to prevent migraines. Its mood-stabilizing properties help in maintaining mental health balance in patients with bipolar disorder.

The prolonged-release nature of Divalxyle ER 500 Tablet helps minimize fluctuations in drug levels, offering more consistent symptom control and reducing the risk of adverse effects commonly associated with fluctuating blood levels. This formulation is designed for patients who require long-term management of their conditions, ensuring that therapeutic levels of the drug are maintained over extended periods.

Read More

About the Product

Divalproex  ER 500 Tablet is a prolonged-release formulation containing Divalproex Sodium, a medication widely used in the management of neurological and psychiatric conditions. The extended-release mechanism of Divalxyle ensures a steady release of the active ingredient, providing continuous therapeutic effects throughout the day. This formulation reduces the frequency of dosing, improving patient adherence and optimizing treatment outcomes.

Divalproex is a broad-spectrum anticonvulsant that works by stabilizing electrical activity in the brain, making it highly effective in treating epilepsy. It is also used to manage bipolar disorder, specifically for controlling manic episodes, and to prevent migraines. Its mood-stabilizing properties help in maintaining mental health balance in patients with bipolar disorder.

The prolonged-release nature of Divalxyle ER 500 Tablet helps minimize fluctuations in drug levels, offering more consistent symptom control and reducing the risk of adverse effects commonly associated with fluctuating blood levels. This formulation is designed for patients who require long-term management of their conditions, ensuring that therapeutic levels of the drug are maintained over extended periods.

Possible side effects include nausea, dizziness, weight gain, tremors, and, rarely, liver dysfunction.

Divalxyle ER 500 Tablet is indicated for the treatment of epilepsy, the management of bipolar disorder, and the prevention of migraine headaches.

This medication should only be taken as prescribed by a healthcare provider. Regular liver function and blood parameter monitoring are recommended during treatment.

Store in a cool, dry place at a temperature not exceeding 30°C. Keep the medication in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation